The impact of intravenous fat emulsion administration in acute lung injury

被引:68
作者
Lekka, ME
Liokatis, S
Nathanail, C
Galani, V
Nakos, G
机构
[1] Univ Ioannina, Sch Med, Dept Chem, Intens Care Unit Dept, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Dept Anat & Histol, GR-45110 Ioannina, Greece
关键词
parenteral nutrition; medium-chain triglycericles/long-chain triglycerides; phospholipase A(2); platelet-activating factor-acetylhydrolase; platelet-activating factor;
D O I
10.1164/rccm.200305-620OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The aim of this study was to evaluate the effect of parenteral nutrition containing medium- and long-chain triglycerides on the function of the respiratory system and to investigate mechanisms involved in this process. We studied 13 patients with acute respiratory distress syndrome (ARDS), 8 receiving lipid and 5 placebo, and 6 without ARDS, receiving lipid. Bronchoalveolar lavage (BAL) was performed before and 1 hour after administration of lipid or placebo. In patients with ARDS, lipid administration resulted in deterioration of oxygenation (Pa-O2/Fi(O2): from 129 +/- 37 to 95 +/- 42), compliance of respiratory system (from 39.2 +/- 12 to 33.1 +/- 9.2 ml/cm H2O), and pulmonary vascular resistance (from 258 +/- 47 to 321 +/- 58 dyne.s.cm(-1)). In the BAL fluid of the same group, an increase in total protein and phospholipid concentrations, phospholipase activities, platelet-activating factor and neutrophils, as well as alterations in BAL lipid profile were observed. No significant changes were observed in the control or in the ARDS-Placebo groups. In conclusion, this study indicates that administration of medium- and long-chain triglycerides in patients with ARDS causes alterations in lung function and hemodynamics. Inflammatory cells, possibly activated by lipids, release phospholipase A(2) and platelet-activating factor, enhancing edema formation, inflammation, and surfactant alterations.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 36 条
[1]  
BACHOFEN M, 1982, CLIN CHEST MED, V3, P35
[2]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[3]   The lipids of pulmonary surfactant: Dynamics and interactions with proteins [J].
Batenburg, JJ ;
Haagsman, HP .
PROGRESS IN LIPID RESEARCH, 1998, 37 (04) :235-276
[4]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]   PLATELET-ACTIVATING-FACTOR PRODUCED BY ENDOTHELIAL-CELLS - A MOLECULE WITH AUTOCRINE AND PARACRINE PROPERTIES [J].
BUSSOLINO, F ;
CAMUSSI, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (02) :327-337
[7]   Mammalian phospholipases A2:: mediators of inflammation, proliferation and apoptosis [J].
Capper, EA ;
Marshall, LA .
PROGRESS IN LIPID RESEARCH, 2001, 40 (03) :167-197
[8]  
CUSS FM, 1986, LANCET, V2, P189
[9]   EFFECT OF PLATELET-ACTIVATING-FACTOR ON AIRWAY VASCULAR-PERMEABILITY - POSSIBLE MECHANISMS [J].
EVANS, TW ;
CHUNG, KF ;
ROGERS, DF ;
BARNES, PJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1987, 63 (02) :479-484
[10]   Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions [J].
Ferezou, J ;
Bach, AC .
NUTRITION, 1999, 15 (01) :44-50